Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
03/2004
03/30/2004CA2296713C Bag for packaging liquid substances for animal artificial insemination
03/25/2004WO2004024227A2 Systems of sperm cell preservation and processing
03/25/2004WO2004024084A2 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling
03/25/2004WO2004023869A1 Use of plag or plag-inhibitors to diagnose and/or treat disease
03/25/2004WO2004023867A2 Transgenic cancer models in fish
03/25/2004WO2004007722A3 Transgenic animal expressing alzheimer’s tau protein
03/25/2004WO2004001409A3 Method for screening modulators of the transmission of immunity
03/25/2004WO2004000011A3 Methods for developing animal models
03/25/2004WO2003104261A3 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto
03/25/2004WO2003081993A3 Transgenic aves producing human polyclonal antibodies
03/25/2004WO2003081992A3 The functional disruption of avian immunoglobulin genes
03/25/2004WO2003075747A3 Contrast agents for magnetic resonance imaging and methods related thereto
03/25/2004WO2003040296A3 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
03/25/2004WO2003014731B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use
03/25/2004US20040058869 Methods and reagents for modulating cholesterol levels
03/25/2004US20040058398 Pancreatic progenitor cells and methods for isolating the same
03/25/2004US20040058366 Comprises DNA coding brain-muscle-arnt-like protein 2 (BMAL2) for diagnosis and treatment of circadian rythm disorders
03/25/2004US20040058326 Identification and use of molecules implicated in pain
03/25/2004US20040058321 Comprises nucleotide sequences coding transforming growth factor binding proteins for diagnosis and treatment of osteoporosis and osteopenia
03/25/2004CA2538118A1 Sperm cell preservation and processing systems
03/25/2004CA2500967A1 Transgenic cancer models in fish
03/25/2004CA2498928A1 Rb pathway and chromatin remodeling genes that antagonize let-60 ras signaling
03/24/2004EP1400592A1 Streptococcus pneumoniae polynucleotides and sequences
03/24/2004EP1400171A1 Transgenic production of antibodies in milk
03/24/2004EP1399575A2 Methods of modifying eukaryotic cells
03/24/2004EP1399553A2 Polynucleotides encoding cellular transporters and methods of use therof
03/24/2004EP1399550A2 Transgenic models for glucose homeostasis comprising human gsk-3
03/24/2004EP1399483A2 Antibodies to insulin-like growth factor i receptor
03/24/2004EP1399016A2 Method for generating diversity
03/24/2004EP1399015A2 Hydrogel beads or capsules as artificial media for insects oviposition and rearing of endoparasitoids
03/24/2004EP0900002B1 H2-m modified transgenic animals
03/24/2004CN2607020Y Woven plastic silkworm net
03/24/2004CN2607019Y Net-type crab enclosure for preventing viral epidemic disease of prawn pool
03/24/2004CN1484707A Methods of modifying eukaryotic cells
03/24/2004CN1484692A Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing canceg said protooncogene
03/23/2004US6710171 Isolated dna encoding protein having specified amino acid sequence; treating or preventing arteriosclerosis and restenosis after treatment of artery occlusion
03/23/2004US6709860 Construct comprising adipose-specific promoter operably linked to nucleotide sequence encoding polypeptide comprising specified amino acid sequence
03/23/2004US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
03/23/2004US6708648 Apparatus for detecting estrus in livestock
03/18/2004WO2004022752A1 Smg-1-binding protein and method of screening substance controlling its activity
03/18/2004WO2004022748A1 Methods for gene silencing in transgenic animals
03/18/2004WO2004022738A1 Methods and compositions for the generation of humanized mice
03/18/2004WO2004022722A2 Lentiviral vectors, related reagents, and methods of use thereof
03/18/2004WO2004022697A2 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
03/18/2004WO2004022089A1 Minibrain homologous proteins involved in the regulation of energy homeostasis
03/18/2004WO2004021977A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
03/18/2004WO2004021781A2 Cryptophlebia leucotreta granulovirus (crlegv-sa) as a biological control agent
03/18/2004WO2004021773A1 Method for feeding social insects and feeding device for social insects
03/18/2004WO2004021772A2 Immune cloning and uses thereof
03/18/2004WO2003099995A3 Murine ortholog of the human disrupted-in-schizophrenia 1 gene
03/18/2004WO2003076950A3 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders
03/18/2004WO2003032809A3 Modulation of akt-dependent response to prevent restenosis
03/18/2004WO2003007800A8 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer
03/18/2004WO2002090567A9 Sperm-specific cation channel, and uses therefor
03/18/2004US20040055030 Sperm cell processing and preservation systems
03/18/2004US20040055029 Genetically distinct strain of channel catfish designated NWAC103, with improved growth performance
03/18/2004US20040055024 Conditional mutants of influenza virus M2 protein
03/18/2004US20040055023 Animal models which concurrently expresses insulin and glucokinase gene in muscle cells; treating pancreatic disorders
03/18/2004US20040055022 Compositions and methods for screening therapeutic agents
03/18/2004US20040054133 Multiple sclerosis-related superantigen
03/18/2004US20040053869 Stem cell differentiation
03/18/2004US20040053833 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds
03/18/2004US20040053812 Methods
03/18/2004US20040053379 Method of producing polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs
03/18/2004US20040053361 Nucleic acid construct useful for expressing transgenes in particular in embryonic stem cells
03/18/2004US20040053299 Regulated activation of cell-membrane receptors by metal-chelating agonists
03/18/2004US20040053278 Smad6 and uses thereof
03/18/2004US20040053269 Proteases
03/18/2004US20040053265 Using differential gene expression of flotillin gene products to diagnose and prognose brain disorders
03/18/2004US20040052896 Process for storing enriched nematodes
03/18/2004US20040050186 A new design of a nozzle interior surface geometry that gently handles and orients a living animal sperm cell sample into a proper radial direction for analyzing and efficient sorting
03/18/2004CA2497902A1 Smg-1 binding protein and screening method for substances that can regulate the activity thereof
03/18/2004CA2497719A1 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
03/18/2004CA2496566A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
03/18/2004CA2496233A1 Methods and compositions for the generation of humanized mice
03/17/2004EP1398323A1 Murine androgen receptor complex-associated protein
03/17/2004EP1397486A2 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
03/17/2004EP0866655B1 Murine model for human carcinoma
03/17/2004CN1483081A New prkag3 allele and its application as genesis and fleshy deseription genetic mark
03/17/2004CN1483074A System for the cell-specific and development-specific selection of differentiating embryonic stem cells, adult stem cells and embryonic germline cells
03/17/2004CN1483040A Heart ankyrin repeat protein gene upstream sequence, carrier containing the same sequence and usage thereof
03/17/2004CN1141874C Artificial reproduction method for Microplitis mediator (Haliday)
03/16/2004US6706947 Method for screening for agents against cancer using an immunosuppression animal model
03/16/2004US6706497 Methods for producing sialyloligosaccharides in a dairy source
03/11/2004WO2004021282A1 Animal behavior analysis method, animal behavior analysis system, animal behavior analysis program, and computer-readable recorded medium on which the program is recorded
03/11/2004WO2004020672A1 Targets for type i and type ii diabetes
03/11/2004WO2004020669A1 Method of using nrse and nrsf
03/11/2004WO2004020665A2 Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases
03/11/2004WO2004020645A2 Chromosomal loci for the stringent control of gene activities via transcription activation systems
03/11/2004WO2004020631A2 Genetic suppression and replacement
03/11/2004WO2004020625A1 SELECTION AND ISOLATION OF LIVING CELLS USING mRNA-BINDING PROBES
03/11/2004WO2004020404A2 Modified transferin-antibody fusion proteins
03/11/2004WO2004019676A2 Animal model for perimenopause and menopause and methods of inducing ovarian failure
03/11/2004WO2003054141A3 Sperm-specific cation channel, catsper2, and uses therefor
03/11/2004WO2003047532A3 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
03/11/2004WO2003018799A3 Modulators of bone homeostasis identified in a high-throughput screen
03/11/2004WO2002095068A3 Engineered secreted alkaline phosphatase (seap) reporter genes and polypeptides
03/11/2004WO2002079441A3 Secreted proteins
03/11/2004WO2002062135A8 Scce modified transgenic mammals and their use as models of human disease
03/11/2004US20040049800 Rapid methods for assessing therapeutic activity using animals expressing constitutively active G protein coupled receptors